Globestar Therapeutics Corp (GSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Total expenses | 130 | 49 | 51 | 74 | 62 |
| Operating Income | -130 | -49 | -51 | -74 | -62 |
| Interest Expense | 45 | 39 | 67 | 87 | 121 |
| Other Income | 0 | 0 | 0 | 0 | 27 |
| Pre-tax Income | -174 | -88 | -118 | -161 | -156 |
| Net Income Continuous | -174 | -88 | -118 | -161 | -156 |
| Net Income | $-174 | $-88 | $-118 | $-161 | $-156 |
| EBITDA(a) | $-89 | $-11 | $15 | $9 | $51 |